HRSA Funding Overview

---

March 2020 – The Department of Health and Human Services released billions of dollars for emergency relief funding during the COVID-19 Pandemic, intended for healthcare providers to meet the increased

health demands of testing and healthcare necessary during the COVID-19 Pandemic.

March 2022 – The HRSA program submission portal was closed, and providers were given little to no notice to submit their healthcare service claims to receive payment.

HRSA Payments

Currently, healthcare providers who were contacted by states and the Federal government through HRSA funding are still waiting on millions of dollars.

In March 2022 over 25 national and state organizations wrote to Speaker Pelosi regarding the notice that the COVID-19 Uninsured Program would no longer be accepting claims due to lack of sufficient funds.

Knightsbridge Holdings in partnership with A10 Associates has been successful in addressing this problem with the Federal Agencies as well as states that should have paid providers through the COVID-19

Uninsured Program. In doing so, we have had success in getting our clients what they are owed from the Federal and State governments.

· Specimen Collection

· Diagnostic & Antibody testing

· Testing related visits

· Office visit

· Telehealth

· Urgent care

· Emergency room

· Inpatient (Hospitalization and ventilators) 

· Outpatient/observation

· SNF/LTAC

· Acute inpatient rehab

· Home Health

· DME

· Ambulance transportation

· FDA-Licensed, authorized, or approved Covid 19

· Dispensing fees for FDA licensed or authorized outpatient antiviral drugs for treatment of Covid-19

· Administration fees related to FDA-authorized or licensed vaccines

· Pharmacies & Pharmacists and those operating under their supervision who are legally authorized by operation of the Public Readiness and Emergency Preparedness (PREP) Act, to order and/or administer testing or vaccination services are eligible to request reimbursement for testing or vaccination administration.